Clinical Trials

Study Title:
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD L1 Negative, Advanced Non Small Cell Lung Cancer

For more information about the trial above please contact the study team:

Principal Investigator, Mariam Alexander, at alexanma@musc.edu.

Study Coordinator, Alexandra Leitner, at leitnera@musc.edu, or please call +1 843-792-1507.

Trial opened at the following institutions: Medical University of South Carolina